In cervical cancer, TIM-3 and its ligand, Galectin-9, are co-repressed by SUV39H1-mediated H3K9me3 and DNMT3A-dependent DNA methylation, resulting in impaired immune recognition and tumor progression. This evidence concerns the gene HAVCR2 and neoplasm.